Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Non-steroidal anti-inflammatory drug Stories

2012-03-14 09:01:00

--Anti-Inflammatory Drugs May Offer Novel Treatment for Heart Disease, Say Gene Researchers in Large Study-- PHILADELPHIA, March 14, 2012 /PRNewswire-USNewswire/ -- A large international study indicates that anti-inflammatory drugs may become a new tool for preventing and treating coronary heart disease (CHD), the leading global cause of death. In investigating a specific gene variant linked to inflammation and heart disease, the researchers used the Cardiochip, a gene analysis...

2012-01-31 06:00:00

GREENWOOD VILLAGE, Colo., Jan. 31, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced preliminary results of the pain score portion of the expansion phase of Ampion(TM) in Knee (AIK) trial which was recently completed in Australia. Preliminary analysis of the pain scores portion of the trial demonstrated positive results,...

2012-01-03 06:00:00

GREENWOOD VILLAGE, Colo., Jan. 3, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that it is has completed the expanded patient enrollment phase of its Ampion(TM) In Knee (AIK) trials in Australia. Forty-two (42) patients were added to the original sixty (60) patient study. Dr. Vaughan Clift, Chief Regulatory...

2011-11-18 06:58:19

Veterinary drug residue in cattle and livestock carcasses is killing South Asian vultures Vultures in South Asia were on the brink of extinction until Lindsay Oaks and Richard Watson, from The Peregrine Fund in the US, undertook observational and forensic studies to find out why the number of birds was falling so rapidly. They discovered the vultures were being poisoned by residues of an anti-inflammatory drug (diclofenac) used in cattle and other livestock, whose carcasses they feed on....

2011-11-05 22:00:00

Falls and fractures among senior citizens have increased since rofecoxib (Vioxx®) was removed from the market in 2004, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago. Chicago, Illinois (PRWEB) November 05, 2011 Falls and fractures among senior citizens have increased since rofecoxib (Vioxx®) was removed from the market in 2004, according to research presented this week at the American College of Rheumatology...

2011-10-26 07:00:00

GREENWOOD VILLAGE, Colo., Oct 26, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced positive results of the Ampion(TM)-In-Knee (AIK) clinical trial. Michael Macaluso, Chairman of the Board, noted that, "In this first ever trial of Ampion(TM) in humans the drug was shown to be well tolerated and reduced pain over and...

2011-10-13 07:00:00

GREENWOOD VILLAGE, Colo., Oct. 13, 2011 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), today announced that it has completed the treatment phase of the Ampion(TM)-in-Knee (AIK) trial. The AIK trial conducted in Australia included 60 patients with moderate to severe osteoarthritis of the knee. Results of this trial will be analyzed and...

2011-09-16 11:22:00

VANCOUVER, Sept. 16, 2011 /PRNewswire/ -- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with a focus on sublingual drug delivery, is pleased to announce that CEO Dr. Hassan Salari will introduce the company to BetterInvesting National Convention participants in a corporate presentation at 1:20 p.m. on Saturday, Sept. 17. Dr. Salari will discuss the company's Sublingual Drug Delivery System and the company's first product in clinical trials, X-Excite, along...

2011-09-07 12:10:40

Many cases of adverse drug reactions (ADRs) seen in hospital and emergency care could be prevented, says a new study to be presented to the annual conference of the International Pharmaceutical federation (FIP) tomorrow (Thursday) . The researchers who carried out the study say that the finding that preventable ADRs are so widespread has important implications for healthcare systems. Pharmacist Katja Hakkarainen, from the Nordic School of Public Health, Gothenburg, Sweden, and colleagues...

2011-09-07 05:59:39

(Ivanhoe Newswire) — Osteoarthritis (OA) affects more than 27 million people in the U.S., causing joint pain and stiffness. This new study shows that chondroitin sulfate significantly decreased pain and improved hand function in patients with OA of the hand. In addition, chondroitin sulfate improved grip strength and relieved morning stiffness. Approximately 10% of the world population, 60 years and older, have symptomatic osteoarthritis according to the Global Burden of Disease 2000...